Lupin Limited Lupin Limited

Lupin Limited

LUPIN

株式のランク #2104
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
株価
$21.43
時価総額
$9.80B
変化(1日)
0.14%
変化(1年)
-2.88%
国
IN
取引 Lupin Limited (LUPIN)

カテゴリー

Healthcare
Lupin Limited(LUPIN)の株式分割履歴
Lupin Limited株(シンボル:LUPIN)は合計で2回の株式分割を実施しました。
最新の株式分割はAug 27, 2010に行われました。
Aug 11, 2006より前に購入されたLUPIN株は、現在10LUPIN株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2010-08-27 5:1 x5 x10
2006-08-11 2:1 x2 x2
類似企業または競合他社の株式分割